General Information of Drug (ID: DM1LVRP)

Drug Name
IC-747 Drug Info
Synonyms LFA-1 antagonists, ICOS/Biogen
Indication
Disease Entry ICD 11 Status REF
Psoriasis vulgaris EA90 Discontinued in Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM1LVRP

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Discontinued Drug(s)
Preclinical Drug(s)
Investigative Drug(s)
Drug(s) Targeting Integrin alpha-L (ITGAL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
lifitegrast DM4WVC5 Dry eye disease 9E1Z Approved [3]
Efalizumab DMCKL5V Psoriasis vulgaris EA90 Approved [4]
BMS-587101 DMS2IC9 Psoriasis vulgaris EA90 Discontinued in Phase 2 [5]
Cytolin DMV8APG Human immunodeficiency virus infection 1C62 Preclinical [6]
A-286982 DM98VFW Discovery agent N.A. Investigative [7]
Leukotoxin DMYX2NJ Autoimmune diabetes 5A10 Investigative [8]
LFA703 DM5G307 Discovery agent N.A. Investigative [9]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Integrin alpha-L (ITGAL) TT48WR6 ITAL_HUMAN Antagonist [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015378)
2 HECA-452+ T Cells Migrate Through Superficial Vascular Plexus but Not Through Deep Vascular Plexus Endothelium. Journal of Investigative Dermatology. 04/1997; 108(3):343-8.
3 Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118). J Ocul Pharmacol Ther. 2013 May;29(4):395-402.
4 [Successful therapy of discoid lupus erythematosus with efalizumab]. Hautarzt. 2010 Mar;61(3):246-9.
5 Small molecule antagonist of leukocyte function associated antigen-1 (LFA-1): structure-activity relationships leading to the identification of 6-(... J Med Chem. 2010 May 13;53(9):3814-30.
6 Cytokine-induced phagocyte adhesion to human mesangial cells: role of CD11/CD18 integrins and ICAM-1. Am J Physiol. 1991 Dec;261(6 Pt 2):F1071-9.
7 Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5269-73.
8 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2451).
9 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.